Trials / Completed
CompletedNCT00264030
Distal Protection Combined With PTCA in AMI Patients
Distal Protection Combined With PTCA in AMI Patients -- The DIPLOMAT Study.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Cordis US Corp. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to evaluate if use of the AngioGuard™ XP improves myocardial reperfusion after PTCA as assessed by ST segment resolution at the end of PTCA.
Detailed description
This is a prospective, randomized, multicenter trial. Patients will be randomized either to be treated by PTCA only or in combination with the An-gioGuard™ XP device. The patients will be followed for six-months post-procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Angioguard distal protection device | PTCA with the Angioguard distal protection device. |
| OTHER | PTCA | PTCA |
Timeline
- Start date
- 2002-03-01
- Completion
- 2004-08-01
- First posted
- 2005-12-12
- Last updated
- 2008-01-07
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00264030. Inclusion in this directory is not an endorsement.